Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (abre nova janela)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Fonte‎: Crit Care Med 2009;37(4):1299-307.

Indexado‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (abre nova janela)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (abre nova janela)

Ball AM, Winstead PS.

Fonte‎: Pharmacotherapy 2008;28(11):1383-90.

Indexado‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (abre nova janela)

Reducing postburn injury anemia in a Jehovah's Witness patient. (abre nova janela)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Fonte‎: J Burn Care Res 2014;35(4):e258-61.

Indexado‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (abre nova janela)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (abre nova janela)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Fonte‎: Clin Ther 2008;30(12):2324-34.

Indexado‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (abre nova janela)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (abre nova janela)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Fonte‎: Transplant Proc 2015;47(8):2548-51.

Indexado‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (abre nova janela)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (abre nova janela)

Charles A, Purtill M, Napolitano LM.

Fonte‎: Anaesth Intensive Care 2006;34(6):793-6.

Indexado‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (abre nova janela)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (abre nova janela)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Fonte‎: Crit Care Med 1999;27(11):2346-50.

Indexado‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (abre nova janela)

Erythropoietin for critically ill trauma patients: a missed opportunity? (abre nova janela)

Corwin HL, Napolitano LM

Fonte‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indexado‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (abre nova janela)

Postoperative management of severe acute anemia in a Jehovah's Witness. (abre nova janela)

de Araújo Azi LM, Lopes FM, Garcia LV

Fonte‎: Transfusion 2014;54(4):1153-7.

Indexado‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (abre nova janela)

Restrictive transfusion in geriatric trauma patients. (abre nova janela)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Fonte‎: Am Surg 2016;82(1):85-8.

Indexado‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (abre nova janela)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (abre nova janela)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Fonte‎: J Trauma 1998;44(2):361-7.

Indexado‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (abre nova janela)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (abre nova janela)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Fonte‎: Crit Care 2005;9(5):R508-15.

Indexado‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (abre nova janela)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (abre nova janela)

Hong T, Shander A, Agarwal S, Castresana M.

Fonte‎: A A Case Rep 2015;4(10):127-31.

Indexado‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (abre nova janela)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (abre nova janela)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Fonte‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indexado‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (abre nova janela)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (abre nova janela)

Lindholm J, Palmér K, Frenckner B.

Fonte‎: Perfusion 2012;27(4):332-4.

Indexado‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (abre nova janela)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (abre nova janela)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Fonte‎: Am Surg 2010;76(9):951-6.

Indexado‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (abre nova janela)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (abre nova janela)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Fonte‎: Intensive Care Med 2013;39(11):1896-908.

Indexado‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (abre nova janela)

Transfusion-free treatment strategies for acute anemia in critical care. (abre nova janela)

Morgan CA, Byul Sarah S, Forest CP.

Fonte‎: JAAPA 2016;29(8):38-44.

Indexado‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (abre nova janela)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (abre nova janela)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Fonte‎: J Trauma 2008;65(2):285-97.

Indexado‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (abre nova janela)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (abre nova janela)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Fonte‎: J Trauma 2009;67(1):121-4.

Indexado‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (abre nova janela)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (abre nova janela)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Fonte‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indexado‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (abre nova janela)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (abre nova janela)

Posluszny JA Jr, Napolitano LM.

Fonte‎: Transfusion 2014;54(12):3026-34.

Indexado‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (abre nova janela)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (abre nova janela)

Price S, Pepper JR, Jaggar SI.

Fonte‎: Anesth Analg 2005;101(2):325-7.

Indexado‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (abre nova janela)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (abre nova janela)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Fonte‎: Am Surg 2015;81(6):e263-5.

Indexado‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (abre nova janela)

Erythropoietin response is blunted in critically ill patients. (abre nova janela)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Fonte‎: Intensive Care Med 1997;23(2):159-62.

Indexado‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (abre nova janela)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (abre nova janela)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Fonte‎: Br J Anaesth 2005;94(4):442-4.

Indexado‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (abre nova janela)

Management of anemia in patients who decline blood transfusion. (abre nova janela)

Shander A, Goodnough LT

Fonte‎: Am J Hematol 2018;93(9):1183-91.

Indexado‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (abre nova janela)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (abre nova janela)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Fonte‎: Arch Surg 2012;147(3):251-5.

Indexado‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (abre nova janela)

Intravenous iron following cardiac surgery does not increase the infection rate. (abre nova janela)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Fonte‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indexado‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (abre nova janela)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (abre nova janela)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Fonte‎: Crit Care 2015;19:49.

Indexado‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (abre nova janela)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (abre nova janela)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Fonte‎: Crit Care Med 2024;52(4):618-25.

Indexado‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (abre nova janela)